These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cephalosporin therapeutics for intensive care infections.
    Author: Salacata A, Chow JW.
    Journal: New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401.
    Abstract:
    Third generation cephalosporins are valuable agents in the ICU setting because of their broad spectrum of activity, in vitro potency against the Gram-negative bacilli commonly isolated in the ICU, and excellent penetration into most body sites. Multiresistant organisms may emerge as a result of widespread injudicious use of these agents, and this possibility is of special concern since these organisms may be associated with higher mortality rates. Combination therapy may be superior to monotherapy in severely ill patients with Gram-negative bacteremia. Double-beta lactam therapy has been efficacious in selected patients, although this regimen has several theoretical disadvantages. When third-generation cephalosporins are used for Gram-negative rod bacteremia in the ICU, combination therapy with an aminoglycoside should be considered.
    [Abstract] [Full Text] [Related] [New Search]